CompletedNCT04176276
Determining Serum and Urinary Levels of miRNA 192 and miRNA 25 in Patients With and Without Type 2 Diabetes.
Studying Non-genetic systemic disease with glomerulopathy as a major feature
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Pisa
- Principal Investigator
- Anna Solini, MD, PhDUniversity of Pisa
- Intervention
- no interventions required.(other)
- Enrollment
- 300 target
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2018 – 2020
Study locations (1)
- University of Pisa, Pisa, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04176276 on ClinicalTrials.govOther trials for Non-genetic systemic disease with glomerulopathy as a major feature
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07271186Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney DiseaseRegeneron Pharmaceuticals
- RECRUITINGNANCT06622915Cardiac Performance Evaluation in Children With Steroid Dependent vs Steroid Resistant Nephrotic SyndromeSohag University
- RECRUITINGPHASE3NCT05914155Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy with Nephrotic SyndromeShoichi Maruyama MD PhD
See all trials for Non-genetic systemic disease with glomerulopathy as a major feature →